EconomySeverity 3 out of 5: Notable5 hours ago
Sanofi relocates production of type 1 diabetes treatment to Lyon
Sanofi has transferred to France, at its Lyon Gerland site, the production of a biotherapy for type 1 diabetes acquired from the United States in 2023. The group presents this relocation as a commitment to health sovereignty.
69Lyon Gerland1 art. · 1 src.